Helen E.J. Tyrrell

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))

P. Emery, Atul Deodhar, William F. C. Rigby et al. · Annals of the Rheumatic Diseases · 2010 · 345 citations · Full text

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial

Paul P. Tak, William F. C. Rigby, Andrea Rubbert‐Roth et al. · Annals of the Rheumatic Diseases · 2010 · 300 citations · Full text

Modelling the hepatitis C virus epidemic in Australia

Karina Razali, Hla‐Hla Thein, Jane C. Bell et al. · Drug and Alcohol Dependence · 2007 · 130 citations

Infectious Disease Modelling, Hepatitis C, Epidemiological Dynamic +6

Retrospective audit of 957 consecutive 18F-FDG PET–CT scans compared to CT and MRI in 493 patients with different histological subtypes of bone and soft tissue sarcoma

Ruth E. Macpherson, Sarah Pratap, Helen E.J. Tyrrell et al. · Clinical Sarcoma Research · 2018 · 109 citations · Full text

Etrolizumab for the Treatment of Ulcerative Colitis and Crohn’s Disease: An Overview of the Phase 3 Clinical Program

William J. Sandborn, Séverine Vermeire, Helen E.J. Tyrrell et al. · Advances in Therapy · 2020 · 87 citations · Full text